pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

What's next for Medicare's health tech pilot

The Centers for Medicare and Medicaid Services (CMS) held an event this week to mark the launch, earlier this summer, of the ACCESS model — the 10-year pilot program that

Sep 17, 2026·read at Endpoints ↗

September 17, 2026 11:17 AM EDT Health Tech What's next for Medicare's health tech pi­lot Shelby Livingston Health tech correspondent The Cen­ters for Medicare and Med­ic­aid Ser­vices (CMS) held an event this week to mark the launch, ear­li­er this sum­mer, of the AC­CESS mod­el — the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
81 words · retrieved 2m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 57m agoTwo more biotechs, Marea and North Immunology, do reverse mergersEndpoints
  • 1h agoA Parkinson's biotech debut, fundraising campaign and licensing dealEndpoints
  • 1h agoThe Endpoints 11: How we picked 2026's most exciting biotech startupsEndpoints
  • 1h agoRoche eyes label expansion for Lunsumio after confirmatory lymphoma trial winEndpoints
  • 3h agoGeneral Catalyst details tech partnerships at Summa HealthEndpoints